(2023). Cerebral Embolic Protection Devices and Transcatheter Aortic Valve Implantation. Could Neurological Complications Be Avoided? A MetaAnalysis Of 4091 Patients. test, 7(2), -. doi: 10.21608/cvrepj.2023.351302
. "Cerebral Embolic Protection Devices and Transcatheter Aortic Valve Implantation. Could Neurological Complications Be Avoided? A MetaAnalysis Of 4091 Patients". test, 7, 2, 2023, -. doi: 10.21608/cvrepj.2023.351302
(2023). 'Cerebral Embolic Protection Devices and Transcatheter Aortic Valve Implantation. Could Neurological Complications Be Avoided? A MetaAnalysis Of 4091 Patients', test, 7(2), pp. -. doi: 10.21608/cvrepj.2023.351302
Cerebral Embolic Protection Devices and Transcatheter Aortic Valve Implantation. Could Neurological Complications Be Avoided? A MetaAnalysis Of 4091 Patients. test, 2023; 7(2): -. doi: 10.21608/cvrepj.2023.351302

Cerebral Embolic Protection Devices and Transcatheter Aortic Valve Implantation. Could Neurological Complications Be Avoided? A MetaAnalysis Of 4091 Patients

Cardiovascular Research Prove Journal
Volume 7, Issue 2, December 2023    PDF (116.84 K)
Document Type: Abstracts
DOI: 10.21608/cvrepj.2023.351302
Abstract
Transcatheter aortic valve implantation (TAVI)
has become an established treatment option for
the treatment of aortic stenosis throughout the
spectrum of surgical risk. Cerebral embolic
protection devices (CEPDs) were developed to 
protect against embolization from the valve or 
vasculature during or post- surgery.
Statistics
Article View: 69
PDF Download: 33